That Health Rules

Although Several Preliminary results of the effectiveness of other Covid-19 vaccines across different populations have been published….However, existing vaccine-effectiveness estimates have focused mainly on outcomes of the messenger RNA vaccine (Pfizer–BioNTech and Moderna), (Oxford–AstraZeneca), and JJ.

Data on vaccine effectiveness in the prevention of Covid-19 using Inactivated Virus like SINOVAC are definitely lacking up to now.

Now comes this new data from Chile that provide us with Real World Evidence on Coronvac/ Sinovac Effectiveness against Covid 19 Infection.

Our goal during this COVID pandemic is simply to get as many people healthy or with co-morbidities, young or old to get vaccinated with COVID 19 Vaccine.

However, while we are very busy with Covid 19, data have shown that In any given year, anywhere from 12,000 to 60,000 people will die from another virus causing disease called flu which we know is actually a preventable disease since we have the yearly flu vaccination.

The sad reality is less than 50% of eligible adults for flu vaccine get vaccinated.

So, Do we need to get flu vaccinated this year?

Can the flu vaccine help fight COVID-19 infection? Or can it help reduce severity of illness?

Watch and learn…https://youtu.be/_rU7dU0yPYM

The Delta variant of the virus that causes Covid-19 doubles the risk of hospitalization compared to the Alpha variant and has now become the dominant strain worldwide.

BUT always remember, the vaccine is not 100% protective against Covid 19 infection. It is therefore important not to blame a brand of vaccine on cases where you get Covid infection inspite of vaccination. Whether you got mrna like Pfizer or AZ or Sinovac, breakthrough infections can occur.

Sinovac which is the widely used vaccine in the country and other parts of Asia and China has made a lot worried due to lack of real world data on its effectiveness against the delta variant.

What the world knows is that China’s inactivated vaccines continue to be very protective during a recent outbreak of Covid-19 in the southern Chinese province of Guangdong.

The data from their experience has finally been published pending review which now provides us the real world evidence about the ability of Sinovac to stave off the highly infectious variant.